Literature DB >> 34249420

Development and validation of survival nomograms in colorectal cancer patients with synchronous liver metastases underwent simultaneous surgical treatment of primary and metastatic lesions.

Xiao Guo1, Yang Liu1, Lu-Jia Liu1, Jun Li1, Lei Zhao1, Xiang-Ren Jin1, Wei Yan1, Bai-Qiang Lin1, Shang Shi1, Zhi-Yong Li1, Shuang Wang1, Xin Wu1, Hong-Ye Chen1, Yang Shen1, Yun-Wei Wei1.   

Abstract

Colorectal cancer patients with synchronous liver metastases (CRSLM) can be treated by simultaneous surgery, that is the primary tumor and liver metastasis are removed at the same time. However, criteria for simultaneous surgery are underwent continuously modified and expanded. An appropriate selection of adequate candidates for simultaneous surgery is vital to get best benefits. A retrospective study including CRSLM patients underwent simultaneous surgical treatment was conducted. CRSLM patients from SEER database were screened as development set, while CRSLM patients in Harbin (China) were enrolled as validation set. Overall survival (OS) and cancer-specific survival (CSS) were applied as end-point. Variables were screen by LASSO-Cox regression, then Cox regression was applied to construct 1-, 3- and 5-year OS, and CSS nomograms. Nomograms were compared to TMN stage for survival prediction and evaluated by concordance indexes (C-indexes), Time-dependent receiver operating characteristic (ROC) curves, Decision Curve Analysis (DCA). 1347 and 112 CRSLM patients were included in the development set and validation set respectively. Nine factors were found associated with OS and CSS, i.e., Age, Primary Site, Differentiation grade, Histology type, T stage, N stage, Tumor size, Chemotherapy, CEA. Compared to the TNM stage, OS nomogram in development set and validation set got C-indexes values of 0.701 vs 0.641, 0.670 vs 0.557 respectively. Meanwhile, compared to the TNM stage, CSS nomogram in development set and validation set got C-indexes values of 0.704 vs 0.649, 0.677 vs 0.569 respectively. AUC values of the OS and CSS nomograms were higher than the TNM stage, DCA showed the OS and CSS nomograms got more clinical net benefit than the TNM stage, in both the development set and validation set. Our nomograms for predicting survival might be helpful to identify the right CRSLM patients who can get most benefit from simultaneous surgery. AJCR
Copyright © 2021.

Entities:  

Keywords:  SEER; Survival nomogram; colorectal cancer; liver metastases

Year:  2021        PMID: 34249420      PMCID: PMC8263634     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  35 in total

1.  Survival analysis and prognostic nomogram for patients undergoing resection of extrahepatic cholangiocarcinoma.

Authors:  N A van der Gaag; J J Kloek; J K de Bakker; B Musters; R B Geskus; O R C Busch; A Bosma; D J Gouma; T M van Gulik
Journal:  Ann Oncol       Date:  2012-04-24       Impact factor: 32.976

2.  Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study.

Authors:  Jin-Huan Wei; Zi-Hao Feng; Yun Cao; Hong-Wei Zhao; Zhen-Hua Chen; Bing Liao; Qing Wang; Hui Han; Jin Zhang; Yun-Ze Xu; Bo Li; Ji-Tao Wu; Gui-Mei Qu; Guo-Ping Wang; Cong Liu; Wei Xue; Qiang Liu; Jun Lu; Cai-Xia Li; Pei-Xing Li; Zhi-Ling Zhang; Hao-Hua Yao; Yi-Hui Pan; Wen-Fang Chen; Dan Xie; Lei Shi; Zhen-Li Gao; Yi-Ran Huang; Fang-Jian Zhou; Shao-Gang Wang; Zhi-Ping Liu; Wei Chen; Jun-Hang Luo
Journal:  Lancet Oncol       Date:  2019-03-14       Impact factor: 41.316

3.  CpG Methylation Signature Predicts Recurrence in Early-Stage Hepatocellular Carcinoma: Results From a Multicenter Study.

Authors:  Jiliang Qiu; Baogang Peng; Yunqiang Tang; Yeben Qian; Pi Guo; Mengfeng Li; Junhang Luo; Bin Chen; Hui Tang; Canliang Lu; Muyan Cai; Zunfu Ke; Wei He; Yun Zheng; Dan Xie; Binkui Li; Yunfei Yuan
Journal:  J Clin Oncol       Date:  2017-01-09       Impact factor: 44.544

4.  Nomogram predicted disease free survival for colorectal liver metastasis patients with preoperative chemotherapy followed by hepatic resection.

Authors:  Wei Liu; Kun Wang; Yu Han; Jie-Ying Liang; Yu-Hong Li; Bao-Cai Xing
Journal:  Eur J Surg Oncol       Date:  2019-06-25       Impact factor: 4.424

5.  A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Authors:  Toru Beppu; Yoshihiro Sakamoto; Kiyoshi Hasegawa; Goro Honda; Kuniya Tanaka; Yoshihito Kotera; Hiroyuki Nitta; Hiroyuki Yoshidome; Etsuro Hatano; Masaki Ueno; Hiroyuki Takamura; Hideo Baba; Tomoo Kosuge; Norihiro Kokudo; Keiichi Takahashi; Itaru Endo; Go Wakabayashi; Masaru Miyazaki; Shinji Uemoto; Tetsuo Ohta; Ken Kikuchi; Hiroki Yamaue; Masakazu Yamamoto; Tadahiro Takada
Journal:  J Hepatobiliary Pancreat Sci       Date:  2012-01       Impact factor: 7.027

6.  Prognostic models for predicting death after hepatectomy in individuals with hepatic metastases from colorectal cancer.

Authors:  Yukihide Kanemitsu; Tomoyuki Kato
Journal:  World J Surg       Date:  2008-06       Impact factor: 3.352

7.  Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis.

Authors:  Giammauro Berardi; Zenichi Morise; Carlo Sposito; Kazuharu Igarashi; Valentina Panetta; Ilaria Simonelli; Sungho Kim; Brian K P Goh; Shoji Kubo; Shogo Tanaka; Yutaka Takeda; Giuseppe Maria Ettorre; Gregory C Wilson; Matteo Cimino; Chung-Yip Chan; Guido Torzilli; Tan To Cheung; Hironori Kaneko; Vincenzo Mazzaferro; David A Geller; Ho-Seong Han; Akishige Kanazawa; Go Wakabayashi; Roberto Ivan Troisi
Journal:  J Hepatol       Date:  2019-09-06       Impact factor: 25.083

Review 8.  Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases.

Authors:  R P Jones; R Jackson; D F J Dunne; H Z Malik; S W Fenwick; G J Poston; P Ghaneh
Journal:  Br J Surg       Date:  2012-01-19       Impact factor: 6.939

9.  Early T Stage Is Associated With Poor Prognosis in Patients With Metastatic Liver Colorectal Cancer.

Authors:  Lunpo Wu; Jianfei Fu; Yi Chen; Liangjing Wang; Shu Zheng
Journal:  Front Oncol       Date:  2020-06-18       Impact factor: 6.244

Review 10.  Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies.

Authors:  P C Simmonds; J N Primrose; J L Colquitt; O J Garden; G J Poston; M Rees
Journal:  Br J Cancer       Date:  2006-04-10       Impact factor: 7.640

View more
  3 in total

1.  Risk factors for and predictive nomogram of overall survival in adult patients with craniopharyngiomas: A SEER population-based study.

Authors:  Yong Wu; Bo Xu; Sheng Hu; Bi-Bo Shao
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

2.  Nomogram Predicting the Survival of Young-Onset Patients with Colorectal Cancer Liver Metastases.

Authors:  Xiaofei Cheng; Yanqing Li; Dong Chen; Xiangming Xu; Fanlong Liu; Feng Zhao
Journal:  Diagnostics (Basel)       Date:  2022-06-04

3.  Predicting Survival for Hepatic Arterial Infusion Chemotherapy of Unresectable Colorectal Liver Metastases: Radiomics Analysis of Pretreatment Computed Tomography.

Authors:  Peng Liu; Haitao Zhu; Haibin Zhu; Xiaoyan Zhang; Aiwei Feng; Xu Zhu; Yingshi Sun
Journal:  J Transl Int Med       Date:  2022-04-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.